Astellas Appoints President Of Americas Operations
This article was originally published in Scrip
Executive Summary
Astellas Pharma Inc. has promoted James Robinson from president, Astellas Pharma US to president of Americas Operations, for Astellas US LLC – effective April 1, 2016. Robinson, who joined the company in 2005 as vice president of health systems, and was named senior vice president of sales and marketing in 2011, will succeed Masao Yoshida, who is retiring in June 2016. Robinson started his career at Schering-Plough in 1992 as a sales representative.
You may also be interested in...
Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Adherence Issues Add Weight To Digital Trials Push
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.